Shalby Hospitals IPO Subscribed 1.08 Times On The Final Bidding Day
The initial public offer of Shalby Hospitals Ltd. got fully subscribed on the final day of bidding on Thursday.
The IPO, which aims to raise Rs 504 crore, received bids for over nearly 1.54 crore shares versus the total issue size of 1.43 crore, making the issue oversubscribed by 1.08 times, according to data provided by issue manager Axis Capital as of 11 am.
The portion reserved for qualified institutional buyers was subscribed by 1.97 times the number of shares on offer, while the retail investor portion was subscribed 1.04 times. The non-institutional bidders segment saw muted demand and the shares set aside for employees received bids for 0.02 times the number of shares allotted.
Ahead of the public issue, the super-specialty hospital chain raised over Rs 150 crore from anchor investors.
Also Read: Shalby Hospitals IPO: Here's All You Need To Know
The IPO of the Ahmedabad-based company comprises a fresh issue of shares aggregating up to Rs 480 crore and an offer for sale of up to 10 lakh equities. The price band has been fixed at Rs 245-248. At the upper end, the public issue would fetch Rs 504 crore.
Proceeds of the IPO will be utilised towards repayment of borrowings by the company, besides purchase of medical equipment for the existing, recently set-up as well as upcoming hospitals.
In recent months, healthcare services firms Alkem Laboratories, Dr Lal Pathlabs, Narayana Hrudayalaya, Thyrocare and Eris Lifesciences have tapped the primary market through the IPO route.
With inputs from PTI
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.
-
When Everyone Has AI, What Gives You An Edge?
India's young workforce is entering an uncertain world of work where powerful AI tools are becoming widely accessible. The advantage will belong to those who combine deep expertise with digital fluency, and the distinctly human capabilities that technology cannot manufacture.
-
Wrong Labels, High Pesticide Residues Holding Back Agri Exports | The Reason Why
India needs stronger domestic food-safety and labelling standards, with best practices becoming part of everyday business for farmers, traders and food companies.
